COMP <GO>
RMTI vs UNH // 10Y YIELD & FRED MACRO BETA
Rockwell Medical Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: RMTI 0
— UNH 9
■ METRIC PARITY
LAST: $6.91 (-2.26%) • MKT CAP: $27.9M
macro-sensitivity
—
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
macro-sensitivity
0.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RMTI VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RMTI | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 16.90% | 88.31% | -71.41 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.60% | 12.38% | -22.98 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.24% | 6.25% | -8.49 | UNH | /fcf-yield <GO> |
| Operating Margin | -6.80% | 5.32% | -12.12 | UNH | /operating-margins <GO> |
| Net Profit Margin | -7.70% | 3.53% | -11.23 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | — | 3.33% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.09 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.8 | 55.1 | -15.30 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $27.9M | $359.43B | -$359.41B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RMTI REV | UNH REV | RMTI GROSS % | UNH GROSS % | RMTI FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $69.3M | $447.57B | 16.9% | 88.7% | -$659.0K | $16.07B |
| FY 2024 | $101.5M | $400.28B | 17.2% | 88.3% | $4.2M | $20.70B |
| FY 2023 | $18.7M | $371.62B | — | 89.6% | -$9.4M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RMTI // BETA —
UNH // BETA 0.33